The study to reduce the hemolysis side effect of puerarin by a submicron emulsion delivery system

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 1, 2008, Pages 45-50

  Yue, Peng Fei ^a,b   Yuan, Hai Long ^a   Zhu, Wei Feng ^b   Cong, Long Bo ^b   Xie, Huan ^a,c   Liu, Zhi Guo ^a   Wang, Lu Jun ^a   Xiao, Xiao He ^a  

^a BEIJING 302 HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Blood cell count; Hemolysis; Puerarin; Submicron emulsion

Indexed keywords

HAPTOGLOBIN; HEMOGLOBIN; PHOSPHOLIPID; PUERARIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG SAFETY; ERYTHROCYTE COUNT; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; INTRAVASCULAR HEMOLYSIS; LOW DRUG DOSE; MALE; MICROEMULSION; NONHUMAN; OSMOTIC FRAGILITY; PARTICLE SIZE; PROTEIN BLOOD LEVEL; RABBIT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; DRUG DELIVERY SYSTEMS; EMULSIONS; HEMOLYSIS; ISOFLAVONES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; RABBITS;

EID: 37849046449     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.45     Document Type: Article

References (27)

1. Keung W. M., Vallee B. L., Phytochemistry, 47, 449-453 (1996).
2. Liu Q., Lu Z., Wang L. J., Tongji Med. Univ., 20, 43-45 (2000).
3. Guerra M. C., Speroni E., Broccoli M., Cangini M., Pasini P., Minghetti A., Crespi-Perellino N., Mirasoli M., Cantelli-Forti G., Paolini M., Life Sci., 67, 2997-3006 (2000).
4. Lu X. R., Gao E., Xu L. Z., Li H. Z., Kang B., Chen W. N., Chen S. M., Chai X. S., Chin. Med. J., 100, 25-28 (1987).
5. Liao H. B., He Z. F., Wang G. C., Li H. J., Yue C. J., Chen X. F., Sci. Technol. Food Ind., 24, 81-82 (2003).
6. Xuan B., Zhou Y. H., Yang R. L., J. Ocul. Pharmacol. Ther., 15, 207-216 (1999).
7. Fan L. L., Sun L. H., Li J., Chin. Med. J., 105, 7-11 (1992).
8. Zhang L. N., Shi H. Q., Chinese Journal of Drug Application and Monitoring, 3, 1672-1674 (2004).
9. Zhu Y. Z., Jiang B., Ma M. X., Chinese Journal of Newdrugs and Clinical Remedies, 22, 699-705 (2003).
10. Kawakami S., Yamashita F., Hasida M.. Adv. Drug Deliv. Rev., 45, 77-88 (2000).
11. Mizushima Y., Shoji Y., Kato T., Fukushima M., Kurozumi S., J. Pharm. Pharmacol., 38, 132-134 (1986).
12. Venkataram S., Awini W. M., Jordan K., Rahman Y. E., J. Pharm. Sci., 79, 216-219 (1990).
13. Forster D., Washington C., Davis S. S., J. Pharm. Pharmacol., 40, 325-328 (1988).
14. Kiefer M., Thesis Freiburg, 56, 135-142 (1990).
15. Fukui H., Koike T., Saheki A., Sonoke S., Seki J., Int. J. Pharm., 265, 37-45 (2003).
16. Dirk L. T., Bradley D., Andersonb W. J. P., Adv. Drug Deliv. Rev., 20, 155-164 (1996).
17. Levy M. Y., Langerman L., Gottschalk-Sabag S., Simon B., Pharm. Res., 6, 510-516 (1989).
18. Li Y., Pan W. S., Chen S. L., Yang D. J., Chen X. Z., Xu H. X., Chinese Pharmaceut. J., 41, 1162-1167 (2006).
19. Sano-Martins I. S., Santoro M. L., Morena P., Sousa-E-Silva M. C., Tomy S. C., Antonio L. C., Nishikawa A. K., Goncalves I. L., Larsson M. H., Hagiwara M. K., Larsson D. L., Braz. J. Med. Biol. Res., 28, 303-312 (1995).
20. Dacie S. J., Lewis S. M., "Practical Haematology," Churchill Livingstone, New York, 1995.
21. Wang L. X., He H. B., Tang X., Shao R. Y., Chen D. W., Int. J. Pharm., 323, 161-167 (2006).
22. Yue P. F., You R. H., Yang M., Yuan H. L., Chinese J. Pharmaceut., 38, 491-495 (2007).
23. Seiberta C. S., Oliveirab M. R. L., Goncalvesa L. R. C., Santoroa M. L., Sano-Martinsa I. S., Toxicon, 44, 793-799 (2004).
24. Lin J., Hou S. Z., Li G., Huang Y. C., Zhang M., Wu Y. H., World Science and Technology/Modernization of Traditional Chinese Medicine and Materia Medica, 7, 48-52 (2005).
25. Lichtenberger L. M., Graziani L. A., Dial E. J., Butler B. D., Hills B. A., Science, 3219, 1327-1329 (1994).
26. Martin G. P., Marriott C., J. Pharm. Pharmacol., 31, 754-759 (1981).
27. Newbery R. S., Turner N. C., Martin G. P., Marriott C., Gastric U., J. Pharm. Pharmacol., 36 (Suppl.), 44-48 (1984).